D. OSMANİYE Et Al. , "Synthesis and biological evaluation of novel 1,3,4-oxadiazole derivatives as anticancer agents and potential EGFR inhibitors," JOURNAL OF HETEROCYCLIC CHEMISTRY , vol.59, no.3, pp.518-532, 2022
OSMANİYE, D. Et Al. 2022. Synthesis and biological evaluation of novel 1,3,4-oxadiazole derivatives as anticancer agents and potential EGFR inhibitors. JOURNAL OF HETEROCYCLIC CHEMISTRY , vol.59, no.3 , 518-532.
OSMANİYE, D., Gorgulu, S., SAĞLIK, B. N., LEVENT, S., ÖZKAY, Y., & KAPLANCIKLI, Z. A., (2022). Synthesis and biological evaluation of novel 1,3,4-oxadiazole derivatives as anticancer agents and potential EGFR inhibitors. JOURNAL OF HETEROCYCLIC CHEMISTRY , vol.59, no.3, 518-532.
OSMANİYE, DERYA Et Al. "Synthesis and biological evaluation of novel 1,3,4-oxadiazole derivatives as anticancer agents and potential EGFR inhibitors," JOURNAL OF HETEROCYCLIC CHEMISTRY , vol.59, no.3, 518-532, 2022
OSMANİYE, DERYA Et Al. "Synthesis and biological evaluation of novel 1,3,4-oxadiazole derivatives as anticancer agents and potential EGFR inhibitors." JOURNAL OF HETEROCYCLIC CHEMISTRY , vol.59, no.3, pp.518-532, 2022
OSMANİYE, D. Et Al. (2022) . "Synthesis and biological evaluation of novel 1,3,4-oxadiazole derivatives as anticancer agents and potential EGFR inhibitors." JOURNAL OF HETEROCYCLIC CHEMISTRY , vol.59, no.3, pp.518-532.
@article{article, author={DERYA OSMANİYE Et Al. }, title={Synthesis and biological evaluation of novel 1,3,4-oxadiazole derivatives as anticancer agents and potential EGFR inhibitors}, journal={JOURNAL OF HETEROCYCLIC CHEMISTRY}, year=2022, pages={518-532} }